Zentalis Pharmaceuticals, Inc.盘中异动股价大跌5.91%报3.27美元

市场透视11-18

北京时间2024年11月18日22时53分，Zentalis Pharmaceuticals, Inc.（ZNTL.us）股票出现异动，股价急速下挫5.91%。截至发稿，该股报3.27美元/股，成交量8.5423万股，换手率0.12%，振幅5.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-40.16百万美元，每股收益-0.56美元，毛利-321000.00美元，市盈率-1.32...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2484167426?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-18 22:53","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2484167426","market":"us","top_or_hot":-1,"title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.91%报3.27美元","media":"市场透视","content":"<div>\n<p>北京时间2024年11月18日22时53分，Zentalis Pharmaceuticals, Inc.（ZNTL.us）股票出现异动，股价急速下挫5.91%。截至发稿，该股报3.27美元/股，成交量8.5423万股，换手率0.12%，振幅5.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-40.16百万美元，每股收益-0.56美元，毛利-321000.00美元，市盈率-1.32...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822530198e43452&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.91%报3.27美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.91%报3.27美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-18 22:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822530198e43452&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月18日22时53分，Zentalis Pharmaceuticals, Inc.（ZNTL.us）股票出现异动，股价急速下挫5.91%。截至发稿，该股报3.27美元/股，成交量8.5423万股，换手率0.12%，振幅5.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-40.16百万美元，每股收益-0.56美元，毛利-321000.00美元，市盈率-1.32...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822530198e43452&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZNTL","symbol_name":"Zentalis Pharmaceuticals, LLC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822530198e43452&s=b","article_id":"2484167426","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822530198e43452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2484167426","pubTimestamp":1731941580,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月18日22时53分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.91%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为547.20%、409.52%、298.08%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fate Therapeutics, Inc.，振幅分别为118.81%、71.83%、62.38%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ZNTL":"Zentalis Pharmaceuticals, LLC","BK4139":"生物科技"},"translate_title":"Zentalis Pharmaceuticals, Inc. shares fell 5.91% to $3.27 during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZNTL":0.9},"content_text":"北京时间2024年11月18日22时53分，Zentalis Pharmaceuticals, Inc.（ZNTL.us）股票出现异动，股价急速下挫5.91%。截至发稿，该股报3.27美元/股，成交量8.5423万股，换手率0.12%，振幅5.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-40.16百万美元，每股收益-0.56美元，毛利-321000.00美元，市盈率-1.32倍。机构评级方面，在所有9家参与评级的机构中，56%的券商给予买入建议，44%的券商给予持有建议，无券商给予卖出建议。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 (To Pur Ord)涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为547.20%、409.52%、298.08%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Fate Therapeutics, Inc.，振幅分别为118.81%、71.83%、62.38%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。该公司使用一种药物发现引擎，被称为“集成发现引擎”(Integrated discovery engine)，来识别靶标并开发具有其认为可能导致潜在差异化产品特征的小分子新化学实体(NCEs)。该公司有两个主要候选产品:ZN-c5，用于治疗晚期雌激素受体阳性、人表皮生长因子受体2阴性或ER+/HER2-、晚期或转移性乳腺癌;锌-c3，用于晚期实体瘤和卵巢癌的单药治疗。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484167426"}

Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.91%报3.27美元

精彩评论

Zentalis Pharmaceuticals, Inc.盘中异动股价大跌5.91%报3.27美元